Product Information
CEFPODOXIME 100 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.0093 per ML under NDC 64980040350. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jun 8, 2007.
Strength
100 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980040350
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFPODOXIME PROXETILApproval Type
Generic (ANDA)
FDA Application
ANDA065409FDA Approved
6/8/2007
On Market Since
6/8/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFPODOXIME 100 MG/5 ML SUSP has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0093 per ML |
|---|---|
| All-time high | $1.1888 (Apr 15, 2026) |
| All-time low | $0.6804 (Jul 17, 2024) |
| 52-week high | $1.1888 |
| 52-week low | $0.9381 |
| Median price | $0.9191 |
| Average price | $0.9159 |
| Largest weekly change | +16.1% (Nov 20, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPODOXIME 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 100 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $1.0093 per ML (NDC 64980040350), effective Aug 19, 2026.
How has the price of CEFPODOXIME 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPODOXIME 100 MG/5 ML SUSP has risen 20.3%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFPODOXIME 100 MG/5 ML SUSP?
Since Apr 17, 2024, the NADAC for CEFPODOXIME 100 MG/5 ML SUSP has ranged from a low of $0.6804 (Jul 17, 2024) to a high of $1.1888 (Apr 15, 2026), with a median of $0.9191 per ML.
Are there cheaper alternatives to CEFPODOXIME 100 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPODOXIME 100 MG/5 ML SUSP, is $0.9920 per ML — about 2% below CEFPODOXIME 100 MG/5 ML SUSP.
Who manufactures CEFPODOXIME 100 MG/5 ML SUSP?
CEFPODOXIME 100 MG/5 ML SUSP (NDC 64980040350) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.